Form 8-K - Current report:
SEC Accession No. 0001213900-25-014154
Filing Date
2025-02-14
Accepted
2025-02-14 14:56:58
Documents
16
Period of Report
2025-02-10
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0231142-8k_inmed.htm   iXBRL 8-K 28023
2 RESIGNATION LETTER OF JANET GROVE ea023114201ex99-1_inmed.htm EX-99.1 3187
3 PRESS RELEASE, DATED FEBRUARY 12, 2025 ea023114201ex99-2_inmed.htm EX-99.2 105214
4 GRAPHIC ex99-2_001.jpg GRAPHIC 16622
  Complete submission text file 0001213900-25-014154.txt   349101

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE inm-20250210.xsd EX-101.SCH 3021
6 XBRL LABEL FILE inm-20250210_lab.xml EX-101.LAB 34240
7 XBRL PRESENTATION FILE inm-20250210_pre.xml EX-101.PRE 22364
19 EXTRACTED XBRL INSTANCE DOCUMENT ea0231142-8k_inmed_htm.xml XML 3672
Mailing Address 1445-885 WEST GEORGIA ST. VANCOUVER A1 V6C 3E8
Business Address 1445-885 WEST GEORGIA ST. VANCOUVER A1 V6C 3E8 (604) 669-7207
InMed Pharmaceuticals Inc. (Filer) CIK: 0001728328 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-39685 | Film No.: 25627211
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)